Semler Scientific (SMLR) has a profit margin of 130.8%, above the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2025
Trailing 12 months ending Sep 2025
The latest profit margin for SMLR is 130.8% as of September 2025. That compares with 27.0% in the prior-year period — up 384.4% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Semler Scientific's historical trend and sector peers before judging valuation or financial health.
Over the past year, SMLR's profit margin moved from 27.0% to 130.8% — a 384.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Semler Scientific's valuation or profitability profile.
Against Healthcare companies, SMLR currently prints 130.8% for profit margin, while the sector average sits near 13.89%. That is roughly 842.0% above the sector mean. Large gaps often invite a closer look at Semler Scientific's growth, margins, and balance sheet.
Profit Margin shows how effectively Semler Scientific converts resources into returns. At 130.8%, SMLR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 27.0% in the prior-year period — up 384.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SMLR's profit margin (130.8%), review year-over-year change from 27.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.